Adam Maeder
Stock Analyst at Piper Sandler
(2.28)
# 2,597
Out of 4,905 analysts
89
Total ratings
53.45%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Maintains: Neutral | $18 → $10 | $7.35 | +36.05% | 2 | Jul 9, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $3.5 → $4 | $3.51 | +14.12% | 1 | Jun 18, 2025 | |
| EW Edwards Lifesciences | Maintains: Overweight | $80 → $83 | $76.49 | +8.51% | 15 | May 13, 2025 | |
| NSPR InspireMD | Maintains: Overweight | $4.5 → $4 | $2.39 | +67.36% | 4 | May 12, 2025 | |
| TCMD Tactile Systems Technology | Downgrades: Neutral | $25 → $14 | $9.52 | +47.06% | 3 | May 6, 2025 | |
| RMD ResMed | Maintains: Neutral | $260 → $248 | $257.92 | -3.85% | 3 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $670 → $575 | $518.62 | +10.87% | 19 | Apr 23, 2025 | |
| ABT Abbott Laboratories | Reiterates: Overweight | $133 → $145 | $123.67 | +17.25% | 3 | Apr 17, 2025 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $11 → $8.5 | $10.31 | -17.56% | 7 | Mar 18, 2025 | |
| INSP Inspire Medical Systems | Maintains: Overweight | $260 → $233 | $126.83 | +83.71% | 14 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $20 → $21 | $11.95 | +75.73% | 2 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 → $8 | $3.66 | +118.58% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $8.22 | +143.31% | 8 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.32 | +115.52% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $10 → $18 | $2.31 | +679.22% | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $99 | $41.98 | +135.83% | 3 | May 5, 2022 |
RxSight
Jul 9, 2025
Maintains: Neutral
Price Target: $18 → $10
Current: $7.35
Upside: +36.05%
Sight Sciences
Jun 18, 2025
Maintains: Neutral
Price Target: $3.5 → $4
Current: $3.51
Upside: +14.12%
Edwards Lifesciences
May 13, 2025
Maintains: Overweight
Price Target: $80 → $83
Current: $76.49
Upside: +8.51%
InspireMD
May 12, 2025
Maintains: Overweight
Price Target: $4.5 → $4
Current: $2.39
Upside: +67.36%
Tactile Systems Technology
May 6, 2025
Downgrades: Neutral
Price Target: $25 → $14
Current: $9.52
Upside: +47.06%
ResMed
Apr 24, 2025
Maintains: Neutral
Price Target: $260 → $248
Current: $257.92
Upside: -3.85%
Intuitive Surgical
Apr 23, 2025
Maintains: Overweight
Price Target: $670 → $575
Current: $518.62
Upside: +10.87%
Abbott Laboratories
Apr 17, 2025
Reiterates: Overweight
Price Target: $133 → $145
Current: $123.67
Upside: +17.25%
Vicarious Surgical
Mar 18, 2025
Maintains: Neutral
Price Target: $11 → $8.5
Current: $10.31
Upside: -17.56%
Inspire Medical Systems
Feb 10, 2025
Maintains: Overweight
Price Target: $260 → $233
Current: $126.83
Upside: +83.71%
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $11.95
Upside: +75.73%
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $3.66
Upside: +118.58%
Mar 6, 2024
Maintains: Overweight
Price Target: $15 → $20
Current: $8.22
Upside: +143.31%
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $2.32
Upside: +115.52%
Jan 6, 2023
Upgrades: Overweight
Price Target: $10 → $18
Current: $2.31
Upside: +679.22%
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $41.98
Upside: +135.83%